glp 1 canker sores mouth Oral ulcerations due to drug medications How GLP-1 Drugs Affect Your – Medscape | After all the

Here's the realistic timeline: Phase 3 trials (AMAZE program): - AMAZE 1 (obesity) started February 2026, enrolling ~1,150 participants - Primary completion estimated: June 2029 - Phase 3 in T2D also being planned following the ADA 2026 data US FDA approval (projected): Q4 2030 at the earliest (GlobalData estimate) EU EMA approval (projected): Q1 2031 at the earliest Bulgaria and Eastern Europe: Typically 612 months after EMA approval for market access, depending on national reimbursement negotiations

"If you need to stop semaglutide, it's important to work closely with your healthcare provider

Athletes with pre-existing metabolic issues (like insulin resistance) should exercise extra caution

Their experiences match what clinical studies show